Dr. John Hertig is Founder and President of Hertig Healthcare Advising, Inc and Adjunct Faculty at Purdue University (Indianapolis, USA). Dr. Hertig lectures around the world and publishes on a variety of patient safety, leadership, administration, and health policy topics. He is an Editor-in-Chief for the Journal of Medicine Access and serves as Chair of the Board of Directors of the Collaborative for Evidence-Based Medicines (CEBM) which unites diverse stakeholders to protect patient safety by encouraging use of trusted and tested medicines.

Dr. Hertig is a former member of the United States Food and Drug Administration Drug Safety and Risk Management Advisory Committee. He holds other national and international appointments, including with the International Pharmaceutical Federation, where he is Treasurer for the Hospital Pharmacy Section, and as Past-President of the Board of Directors for the Alliance for Safe Online Pharmacies – Global (ASOP), where he leads efforts to reduce the patient safety impact of illegal and counterfeit online drug distribution worldwide.

He was awarded the ASOP Global Patient Safety Champion Award in 2018. Dr. Hertig received his Bachelor of Science in Pharmaceutical Sciences and Doctor of Pharmacy degrees from Purdue University (USA). He completed a PGY1 pharmacy practice and PGY2 health-system pharmacy administration residency at The Ohio State University Medical Center while also obtaining a Masters degree in Health-System Pharmacy Administration from The Ohio State University (USA).

He is a Certified Professional in Patient Safety (CPPS), a Fellow of the American Society of Health System Pharmacists (FASHP), and a Fellow of the International Pharmaceutical Federation (FFIP).